§2673. Action against health care practitioner or health care provider license prohibited
A licensing board may not revoke, refuse to renew or suspend the license of or take any action against a health care practitioner as defined in Title 24, section 2502, subsection 1-A based solely on the health care practitioner's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device, as long as the recommendations are consistent with medical standards of care. [PL 2015, c. 418, §1 (NEW).]
The licensing agency may not revoke, refuse to renew or suspend the license of or take any action against a health care provider as defined in Title 24, section 2502, subsection 2 based solely on the health care provider’s involvement in the care of an eligible patient using an investigational drug, biological product or device. [PL 2015, c. 418, §1 (NEW).]
SECTION HISTORY
PL 2015, c. 418, §1 (NEW).
Structure Maine Revised Statutes
Chapter 602-A: ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS
22 §2672. Availability of investigational drug, biological product or device by manufacturer
22 §2673. Action against health care practitioner or health care provider license prohibited
22 §2674. Officials, employees and agents of the State
22 §2675. No cause of action created
22 §2676. Clinical trial coverage
22 §2677. Optional participation of health care practitioners and providers